Brendan is a trained Synthetic Biologist, exited biotech CSO/entrepreneur, former investment banker and current venture capitalist. Brendan has over 20 years experience across the deep tech biotechnology value creation chain from academic discovery through tech translation and capital markets.

Brendan holds a Ph.D in Synthetic Biology from the University of Toronto where his "Best Paper Award" Thesis research inspired the technology behind his successful exit at Spindle Biotech.

He has sourced, diligenced, and advised hundreds of companies from biopharma to medical device, biomanufacturing to AI across formation stage to public follow-ons and M&A transactions.